Equities Insights and Analysis Dave’s Analysis: June 23, 2025 Company Overview: Immunic Inc. (NASDAQ: IMUX) Immunic Inc. is a clinical-stage biopharmaceutical company pioneering the development of selective, orally administered Read More » June 24, 2025 No Comments